Skip to main content Help with accessibility Skip to main navigation

Nephrotrans® (sodium bicarbonate) for metabolic acidosis in patients with chronic renal impairment

CCG Approval Status:

Date Added: 26 - Nov - 2024
Amber retained

The Cheshire and Merseyside Area Prescribing Group recommend Nephrotrans® 500mg gastro-resistant capsules as an option for metabolic acidosis in patients with chronic renal impairment who do not tolerate the gastrointestinal adverse effects of standard sodium bicarbonate products.

 

NHS Cheshire and Merseyside APPROVED